REPATRIATION MEDICAL AUTHORITY
INSTRUMENT NO. 88 OF 2007
VETERANS’ ENTITLEMENTS ACT 1986
MILITARY REHABILITATION AND COMPENSATION ACT 2004
EXPLANATORY NOTES FOR TABLING
- The Repatriation Medical Authority (‘the Authority’) has determined, under subsection 196B(3) & (8) of the Veterans’ Entitlements Act 1986 (‘the VEA’) the attached Instrument No. 88 of 2007.
2. This instrument amends Instrument No. 18 of 2006 Statement of Principles concerning malignant neoplasm of the lung (‘the Instrument’).
3. The amendment revises the definition of 'a substance from the specified list' in clause 9 of Instrument No. 18 of 2006.
4. The Instrument specifies a date of effect for the Instrument in accordance with sub-section 12(1)(a) of the Legislative Instruments Act 2003.
5. Prior to determining this instrument, the Authority advertised its intention to undertake an investigation in relation to malignant neoplasm of the lung in the Government Notices Gazette of 28 June 2006, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants. The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field. No submissions were received for consideration by the Authority during the investigation.
6. The determining of this new instrument finalises the investigation in relation to malignant neoplasm of the lung as advertised in the Government Notices Gazette of 2 May 2007.
7. A list of references relating to the above condition is available, on written request, from the Repatriation Medical Authority Secretariat.
Overview
The Repatriation Medical Authority Instrument No. 88 of 2007 amends Instrument No. 18 of 2006, which concerns the Statement of Principles relating to malignant neoplasm of the lung under the Veterans’ Entitlements Act 1986. This legislative instrument was introduced to refine the definition of 'a substance from the specified list' in the aforementioned Instrument No. 18, thereby addressing gaps in the interpretation and application of the existing legislation. The Authority, acting under subsection 196B(3) and (8) of the VEA, finalised this amendment after advertising its intention to investigate in the Government Notices Gazette on 28 June 2006 and soliciting feedback from relevant organisations and experts. This new instrument was determined to be effective as of 2 May 2007, marking the conclusion of the investigation into malignant neoplasm of the lung.
Scope and Application
The Repatriation Medical Authority Instrument No. 88 of 2007 pertains to the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, specifically addressing malignant neoplasm of the lung. This legislative instrument amends the previously established Instrument No. 18 of 2006, refining the definition of 'a substance from the specified list' in clause 9. It is applicable to veterans and their dependants who have been diagnosed with malignant neoplasm of the lung and seeks to provide clarity and updates to the conditions under which such diagnoses are considered for entitlements. The instrument is effective as per the provisions of the Legislative Instruments Act 2003. The Authority's determination follows an investigation that was publicly announced in the Government Notices Gazette, with an opportunity for relevant organisations and experts to submit feedback, although no submissions were received. This instrument aims to finalise the investigation and update the legislative framework accordingly.
Key Provisions
The main operative sections of Instrument No. 88 of 2007 concern the revision of the definition of 'a substance from the specified list' within the Statement of Principles concerning malignant neoplasm of the lung (sections 2 and 3). This revision is a direct result of the Authority's investigation into malignant neoplasm of the lung, as advertised in the Government Notices Gazette on 28 June 2006 (section 5). The instrument, which amends Instrument No. 18 of 2006, specifies a date of effect in accordance with sub-section 12(1)(a) of the Legislative Instruments Act 2003 (section 4). This revision finalises the investigation that was concluded as advertised in the Government Notices Gazette on 2 May 2007 (section 6).
The obligations and requirements imposed by this Act on the parties and entities it governs include the necessity for the Repatriation Medical Authority to conduct investigations into specified conditions affecting veterans, such as malignant neoplasm of the lung. The Authority is required to advertise its intention to investigate in the Government Notices Gazette and to invite submissions from relevant organisations and individuals (section 5). The Authority must also ensure that any new instruments finalise the investigations in a manner that is transparent and accessible to those affected by the condition in question (section 6). Furthermore, the Authority must maintain a list of references relating to the condition under investigation, which can be made available upon written request (section 7).
In terms of consequences for breach, the Explanatory Notes do not explicitly outline any offences, penalties, or civil/criminal consequences for non-compliance with the provisions of this Instrument. However, it is reasonable to infer that any failure to adhere to the requirements of the investigation and instrument-making process could potentially lead to legal challenges or disputes, particularly if the process is deemed not to have been conducted in a fair or transparent manner. The precise legal consequences would depend on the specifics of any such challenges, but they could include court orders requiring the Authority to revisit its procedures or decisions. It is also important to note that the Legislative Instruments Act 2003 provides a framework for the making, reviewing, and repealing of legislative instruments, which could include mechanisms for addressing breaches or non-compliance with the Act’s provisions.